References
- JaysonGCKohnECKitchenerHCLedermannJAOvarian cancerLancet20143841376138824767708
- KornblithABThalerHTWongGQuality of life of women with ovarian cancerGynecol Oncol1995592312427590479
- Bodurka-BeversDBasen-EngquistKCarmackCLDepression, anxiety, and quality of life in patients with epithelial ovarian cancerGynecol Oncol20007830230810985884
- WangLLiuZLiuDLiuCJuanZZhangNDocetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activityInt J Pharm201141319420121540085
- NaikSPatelDSurtiNMisraAPreparation of PEGylated liposomes of docetaxel using supercritical fluid technologyJ Supercrit Fluids201054110119
- ZhaiGXWuJYuBGuoCYangXLeeRJA transferrin receptor-targeted liposomal formulation for docetaxelJ Nanosci Nanotechnol2010105129513621125861
- GrossePYBressolleFPinguetFIn vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-beta-cyclodextrinEur J Cancer1998341681749624253
- HwangHYKimISKwonICKimYHTumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticlesJ Control Release2008128233118374444
- LiXLiRQianXSuperior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rateEur J Pharm Biopharm20087072673418634874
- XuZChenLGuWThe performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinomaBiomaterials20093022623218851881
- LiXWangDZhangJPanWPreparation and pharmacokinetics of docetaxel based on nanostructured lipid carriersJ Pharm Pharmacol2009611485149219903373
- MahapatroASinghDKBiodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccinesJ Nanobiotechnol20119111
- TysonFLBoyerCMKaufmanRExpression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell linesAm J Obstet Gynecol19911656406461679963
- SlamonDJGodolphinWJonesLAStudies of HER-2/neu proto-oncogene in human breast and ovarian cancerScience19892447077122470152
- SandraMSBaselgaSKimSBPertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancerN Engl J Med201537272473425693012
- BerchuckAKamelAWhitakerROverexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancerCancer Res199050408740911972347
- ThielKWGiangrandePHTherapeutic applications of DNA and RNA aptamersOligonucleotides20091920922219653880
- Levy-NissenbaumERadovic-MorenoAFWangAZLangerRFarokhzadOCNanotechnology and aptamers: applications in drug deliveryTrends Biotechnol20082644244918571753
- O’SullivanCKAptasensors – the future of biosensingAnal Bioanal Chem2002372444811939212
- MurphyMBFullerSTRichardsonPMDoyleSAAn improved method for the in vitro evolution of aptamers and applications in protein detection and purificationNucleic Acids Res2003311812519937
- ChenZLiLZhaoHMuXElectrochemical impedance spectroscopy detection of lysozyme based on electrodeposited gold nanoparticlesTalanta2011831501150621238744
- VarshosazJRiahiSGhassamiEJahanian-NajafabadiATransferrin-targeted poly(butylene adipate)/terephthalate nanoparticles for targeted delivery of 5-fluorouracil in HT29 colorectal cancer cell lineJ Bioact Compat Pol2017325503
- VarshosazJGhassamiENoorbakhshAJahanian-NajafabadiAMinayianMBehzadiRPoly (butylene adipate-co-butylene terephtha-late) nanoparticles prepared by electrospraying technique for docetaxel delivery in ovarian cancer induced miceDrug Dev Ind Pharm Accepted for publication
- FarokhzadOCChengJTeplyBATargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci U S A2006103166315632016606824
- VarshosazJTaymouriSHassanzadehFJavanmardSHRostamiMFolated synperonic-cholesteryl hemisuccinate polymeric micelles for the targeted delivery of docetaxel in melanomaBiomed Res Int20152015117
- ElmlundLKäckCAastrupTNicholasIAStudy of the interaction of trastuzumab and SKOV3 epithelial cancer cells using a quartz crystal microbalance sensorSensors2015155884589425763651
- AnidoJMatarPAlbanellJZD1839 a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cellsClin Cancer Res200391274128312684395
- XuZChenLGuWThe performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinomaBiomaterials20093022623218851881
- Noori KoopaeiMKhoshayandMRMostafaviSHDocetaxel loaded PEG-PLGA nanoparticles: optimized drug loading, in-vitro cytotoxicity and in-vivo antitumor effectJ Pharm Res201413819833
- LiuZLiuDWangLZhangJZhangNDocetaxel-loaded pleuronic P123 polymeric micelles: in vitro and in vivo evaluationInt J Mol Sci2011121684169621673916
- RidolfiRLJamehdorMRArberJMHER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approachMod Pathol20001386687310955453
- RajabiPBagheriAHaniMIntratumoral and peritumoral mast cells in malignant melanoma: an immunohistochemical studyAdv Biomed Res201763928503494
- KeumCGNohYWBaekJSPractical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acidInt J Nanomedicine201162225223422114486
- SannaVRoggioAMPosadinoAMNovel docetaxel-loaded NPs based on poly(lactide-co-caprolactone) and poly(lactideco-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studiesNanoscale Res Lett2011619
- JaworekAMicro- and nanoparticle production by electrosprayingPowder Technol20071761835
- SunBRanganathanaBFengSMultifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by trastuzumab for targeted chemotherapy of breast cancerBiomaterials20082947548617953985
- http://www.ema.europa.eu [homepage on the Internet]LondonEuropean Agency for Evaluation of Medicinal ProductsGuidelines for the conduct of pharmacokinetic studies in target animal speciesEMEA/CVMP/133/99-Final Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004355.pdfAccessed November 1, 2017
- TangXWangGShiREnhanced tolerance and antitumor efficacy by docetaxel-loaded albumin nanoparticlesDrug Deliv2016232686269626004129
- WangLLiuZLiuDLiuCJuanZZhangNDocetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activityInt J Pharm201141319420121540085
- LeeSWYunMHJeongSWDevelopment of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery systemJ Control Release201115526227121704664
- HuangJZhangHYuYBiodegradable self-assembled nanoparticles of poly(D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel in breast cancerBiometerials201435550566